AEDG) used in controlled in-vitro research to explore telomere biology pathways, cellular senescence markers, and circadian-related peptide signalling under non-clinical conditions
The overarching material developed and investigated comprises AngIV-based compounds, designed to overcome the limitations of native peptides like AngIV, which suffer from poor metabolic stability and inability to cross the BBB due to their size and hydrophilicity
Just say NO to Tylenol (Acetaminophen linked to autism?) Update from Dr
Getting started is simple
The peptides under investigation, include: Nle-AngIV (Nle-Tyr-Ile-His-Pro-Phe) and its analogs such as D-Nle-YIH, acetyl-NleYIH, -amino butyric acid-YIH, NleYI-amide, and the primary focus, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide (Dihexa)
ACS medicinal Chem